Text size

Teva Pharmaceutical Industries announced Thursday that it had informed the Israel Tax Authority that it will be making a NIS 336 million tax payment pursuant to the provisions of the investment encouragement law. The statute allows Israeli companies to use tax-exempt profits accumulated through 2011 to pay shareholders dividends subject to the payment of taxes at a reduced rate.